Q2 2025 · 13F-HR
StepStone Group LPholdings as filed
Filed 2025-08-13 · accession 0000950123-25-007762
$50.4M
Reported value
14
Positions
2025-06-30
Period end
The Brief · StepStone Group LP · Q2 2025
AI · grounded in 13F
StepStone Group LP established a new position in PATH valued at $16.47M. The fund also initiated new stakes in DKNG for $9.2M and RBRK for $5.39M. Additional new positions include TRDA at $5.12M and PHAT at $4.05M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 90364P105 | PATH | UIPATH, INC. | $16.5M | 32.7% | 1,286,527 | Common | SOLE |
| 26142V105 | DKNG | DRAFTKINGS INC | $9.2M | 18.2% | 214,536 | Common | SHARED |
| 781154109 | RBRK | RUBRIK, INC. | $5.4M | 10.7% | 60,182 | Common | SHARED |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS, INC. | $5.1M | 10.1% | 761,277 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS, INC. | $4.0M | 8.03% | 422,085 | Common | SOLE |
| 10920V404 | — | NEUEHEALTH INC. | $3.6M | 7.19% | 525,247 | Common | SOLE |
| 43157M102 | — | HILLEVAX, INC. | $1.6M | 3.26% | 826,569 | Common | SOLE |
| 70439P108 | PAY | PAYMENTUS HOLDINGS INC | $1.3M | 2.57% | 39,573 | Common | SHARED |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $1.2M | 2.33% | 491,938 | Common | SOLE |
| 85208T107 | CXM | SPRINKLR, INC. | $635,481 | 1.26% | 75,116 | Common | SHARED |
| 722304102 | PDD | PDD HOLDINGS INC. | $625,848 | 1.24% | 7,032 | Common | SHARED |
| 79589L106 | IOT | SAMSARA INC. | $484,878 | 0.96% | 12,189 | Common | SHARED |
| 39957D201 | GROV | GROVE COLLABORATIVE HOLDINGS, INC. | $437,807 | 0.87% | 380,702 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS, INC. | $282,382 | 0.56% | 462,163 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.